149 related articles for article (PubMed ID: 10997878)
1. All-trans retinoic acid significantly reduces the incidence of early hemorrhagic death during induction therapy of acute promyelocytic leukemia.
Visani G; Gugliotta L; Tosi P; Catani L; Vianelli N; Martinelli G; Ottaviani E; Testoni N; Nocentini F; Pastano R; Piccaluga P; Isidori A; Grafone T; Tura S
Eur J Haematol; 2000 Mar; 64(3):139-44. PubMed ID: 10997878
[TBL] [Abstract][Full Text] [Related]
2. All-trans retinoic acid for the treatment of newly diagnosed acute promyelocytic leukemia. Japan Adult Leukemia Study Group.
Kanamaru A; Takemoto Y; Tanimoto M; Murakami H; Asou N; Kobayashi T; Kuriyama K; Ohmoto E; Sakamaki H; Tsubaki K
Blood; 1995 Mar; 85(5):1202-6. PubMed ID: 7858250
[TBL] [Abstract][Full Text] [Related]
3. Effect of all-trans-retinoic acid alone or in combination with chemotherapy in newly diagnosed acute promyelocytic leukaemia.
Colović MD; Janković GM; Elezović I; Vidović A; Bila JS; Novak A; Babić D
Med Oncol; 1997 Jun; 14(2):65-72. PubMed ID: 9330265
[TBL] [Abstract][Full Text] [Related]
4. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
[TBL] [Abstract][Full Text] [Related]
5. Acute promyelocytic leukemia: all-trans retinoic acid (ATRA) along with chemotherapy is superior to ATRA alone.
Advani SH; Nair R; Bapna A; Gladstone B; Kadam P; Saikia TK; Parekh PM; Gopal R; Nair CN
Am J Hematol; 1999 Feb; 60(2):87-93. PubMed ID: 9929098
[TBL] [Abstract][Full Text] [Related]
6. Thrombosis in patients with acute promyelocytic leukemia treated with and without all-trans retinoic acid.
Escudier SM; Kantarjian HM; Estey EH
Leuk Lymphoma; 1996 Feb; 20(5-6):435-9. PubMed ID: 8833399
[TBL] [Abstract][Full Text] [Related]
7. Management of acute promyelocytic leukemia relapse in the ATRA era.
Castagnola C; Lunghi M; Corso A; Tajana M; Zappasodi P; Dabusti M; Lazzarino M; Bernasconi C
Haematologica; 1998 Aug; 83(8):714-7. PubMed ID: 9793255
[TBL] [Abstract][Full Text] [Related]
8. All-transretinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukemia: a pilot study on 26 cases.
Fenaux P; Castaigne S; Dombret H; Archimbaud E; Duarte M; Morel P; Lamy T; Tilly H; Guerci A; Maloisel F
Blood; 1992 Nov; 80(9):2176-81. PubMed ID: 1421389
[TBL] [Abstract][Full Text] [Related]
9. All-transretinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia.
Al Bahar S; Pandita R; Bavishi K; Kreze O
Indian J Cancer; 2004; 41(3):125-8. PubMed ID: 15472411
[TBL] [Abstract][Full Text] [Related]
10. Long-term efficacy of low-dose all-trans retinoic acid plus minimal chemotherapy induction followed by the addition of intravenous arsenic trioxide post-remission therapy in newly diagnosed acute promyelocytic leukaemia.
Lou Y; Qian W; Meng H; Mai W; Tong H; Tong Y; Huang J; Jin J
Hematol Oncol; 2014 Mar; 32(1):40-6. PubMed ID: 23963734
[TBL] [Abstract][Full Text] [Related]
11. Pre-treatment with all-trans retinoic acid accelerates polymorphonuclear recovery after chemotherapy in patients with acute promyelocytic leukemia.
Visani G; Tosi P; Cenacchi A; Manfroi S; Gamberi B; Ottaviani E; Tura S
Leuk Lymphoma; 1994 Sep; 15(1-2):143-7. PubMed ID: 7858492
[TBL] [Abstract][Full Text] [Related]
12. A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group.
Fenaux P; Chastang C; Chevret S; Sanz M; Dombret H; Archimbaud E; Fey M; Rayon C; Huguet F; Sotto JJ; Gardin C; Makhoul PC; Travade P; Solary E; Fegueux N; Bordessoule D; Miguel JS; Link H; Desablens B; Stamatoullas A; Deconinck E; Maloisel F; Castaigne S; Preudhomme C; Degos L
Blood; 1999 Aug; 94(4):1192-200. PubMed ID: 10438706
[TBL] [Abstract][Full Text] [Related]
13. All-trans retinoic acid (ATRA) in the treatment of acute promyelocytic leukemia (APL).
Chim CS; Kwong YL; Liang R; Chu YC; Chan CH; Chan LC; Wong KF; Chan TK
Hematol Oncol; 1996 Sep; 14(3):147-54. PubMed ID: 9119359
[TBL] [Abstract][Full Text] [Related]
14. Frontline therapy of acute promyelocytic leukemia: Randomized comparison of ATRA and intensified chemotherapy versus ATRA and anthracyclines.
Lengfelder E; Görlich D; Nowak D; Spiekermann K; Haferlach C; Krug U; Kreuzer KA; Braess J; Schliemann C; Lindemann HW; Horst HA; Schiel X; Flasshove M; Hecht A; Schnittger S; Schneider S; Wörmann B; Hofmann WK; Berdel WE; Bormann E; Sauerland C; Büchner T; Hiddemann W;
Eur J Haematol; 2018 Feb; 100(2):154-162. PubMed ID: 29114972
[TBL] [Abstract][Full Text] [Related]
15. Results of APL 91 European trial combining ATRA and chemotherapy: presentation of APL 1993 trial.
Fenaux P
Leukemia; 1994; 8 Suppl 3():S70-2. PubMed ID: 7808029
[TBL] [Abstract][Full Text] [Related]
16. Morbidity and costs of remission induction therapy with all-trans retinoic acid compared with standard chemotherapy in acute promyelocytic leukemia.
Eardley AM; Heller G; Warrell RP
Leukemia; 1994 Jun; 8(6):934-9. PubMed ID: 8207987
[TBL] [Abstract][Full Text] [Related]
17. Incidence, clinical features, and outcome of all trans-retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia. The European APL Group.
De Botton S; Dombret H; Sanz M; Miguel JS; Caillot D; Zittoun R; Gardembas M; Stamatoulas A; Condé E; Guerci A; Gardin C; Geiser K; Makhoul DC; Reman O; de la Serna J; Lefrere F; Chomienne C; Chastang C; Degos L; Fenaux P
Blood; 1998 Oct; 92(8):2712-8. PubMed ID: 9763554
[TBL] [Abstract][Full Text] [Related]
18. Role of cytarabine in paediatric acute promyelocytic leukemia treated with the combination of all-trans retinoic acid and arsenic trioxide: a randomized controlled trial.
Zhang L; Zou Y; Chen Y; Guo Y; Yang W; Chen X; Wang S; Liu X; Ruan M; Zhang J; Liu T; Liu F; Qi B; An W; Ren Y; Chang L; Zhu X
BMC Cancer; 2018 Apr; 18(1):374. PubMed ID: 29615003
[TBL] [Abstract][Full Text] [Related]
19. [Effectiveness of trans-retinoic acid in the treatment of acute promyelocytic leukemia: initial results of a multicenter study].
Parovichnikova EN; Savchenko VG; Kliasova GA; Isaev VG; Demidova IA; Ol'shanskaia IuV; Tiurina NG; Tikhonova LIu; Galstian GM; Pivnik AV
Ter Arkh; 1999; 71(7):20-4. PubMed ID: 10481862
[TBL] [Abstract][Full Text] [Related]
20. Treatment with a new synthetic retinoid, Am80, of acute promyelocytic leukemia relapsed from complete remission induced by all-trans retinoic acid.
Tobita T; Takeshita A; Kitamura K; Ohnishi K; Yanagi M; Hiraoka A; Karasuno T; Takeuchi M; Miyawaki S; Ueda R; Naoe T; Ohno R
Blood; 1997 Aug; 90(3):967-73. PubMed ID: 9242525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
